drugset / Trial / NCT06534346

The Food Effect on Pharmacokinetics of DA-302168S

NCT06534346 ↗

Phase 1 Completed 16 enrolled Chendu DIAO Pharmaceutical Group CO., LTD.
RandomizedCrossoverOpen-labelOther

Summary

This study will be conducted to determine the effect of food on the pharmacokinetics characteristic of DA-302168S following administration of a DA-302168S tablet with and without a high-fat meal.

Timeline

Start
2024-07-18
Primary completion
2024-08-03
Completion
2024-08-03

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-302168S Small molecule 15 mg Oral

Indications

No indication recorded.